Study: GPs inflate valuations during fundraising

A University of Oxford analysis of CalPERS’ private equity portfolio has found that GPs inflate valuations of existing portfolio companies while marketing follow-on funds.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this